Fibroblastic stromal cells express receptor activator of NF-κB ligand and support osteoclast differentiation

Journal of Bone and Mineral Research

Volumn 15, Issue 8, 2000, Pages 1459-1466

  Quinn, Julian M W ^a,b   Horwood, Nicole J ^a   Elliott, Jan ^a   Gillespie, Matthew T ^a   Martin, T John ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Extraskeletal; Fibroblastic stromal cells; Osteoclast differentiation; Osteolysis; Receptor activator of NF B ligand

Indexed keywords

ACID PHOSPHATASE; CALCITONIN RECEPTOR; CALCITRIOL; COLONY STIMULATING FACTOR 1; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 11; MESSENGER RNA; OSTEOPROTEGERIN; PARATHYROID HORMONE RELATED PROTEIN; PROSTAGLANDIN E2; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; COCULTURE; FIBROBLAST; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; STROMA CELL;

EID: 0033914968     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.8.1459     Document Type: Article

References (32)

1. Suda T, Takahashi N, Martin TJ 1992 Modulation of osteoclast differentiation. Endocr Rev 13:66-68.
2. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95:3597-3602.
3. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
4. Horwood NJ, Elliott J, Martin TJ, Gillespie MT 1998 Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746.
5. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira dos Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
6. Quinn JMW, Joyner C, Triffitt JT, Athanasou NA 1992 Polymethyl-methacrylate-induced inflammatory macrophages resorb bone. J Bone Joint Surg Br 74:652-658.
7. Quinn JMW, Sabokbar A, Athanasou NA 1996 Cells of the mononuclear phagocyte series differentiate into osteoclastic lacunar bone resorbing cells. J Pathol 179:106-111.
8. Quinn JMW, Matsumura Y, Tarin D, McGee JO'D, Athanasou NA 1994 Cellular and hormonal mechanisms associated with malignant bone resorption. Lab Invest 71:465-471.
9. Quinn JMW, McGee JO'D, Athanasou NA 1998 Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells. J Pathol 184:31-36.
10. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, Dubose RF, Cosman D, Galibert L 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.
11. Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JMW, Niforas P, Ng KW, Martin TJ, Gillespie MT 1999 Localization of RANKL (receptor activator of NF-kB ligand) mRNA in skeletal and extraskeletal tissue. Bone 25: 525-534.
12. Athanasou NA, Quinn J, Ferguson DJP, McGee JO'D 1991 Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath. Br J Cancer 63:527-533.
13. Athanasou NA, Wells CA, Quinn J, Ferguson DP, Heryet A, McGee JO'D 1989 The origin and nature of stromal osteoclast-like multinucleated giant cells in breast carcinoma: Implications for tumour osteolysis and macrophage biology. Br J Cancer 59:491-498.
14. Athanasou NA, Quinn J 1992 Bone resorption by macrophage polykaryons of a pilar tumor of scalp. Cancer 70: 469-475.
15. Neale S, Kristelly R, Gundle R, Quinn JMW, Athanasou NA 1997 Giant cells in pigmented villo nodular synovitis express an osteoclast phenotype. J Clin Pathol 50:605-608.
16. Khan ZM, Cockerell CJ 1997 Atypical fibroxanthoma with osteoclast-like multinucleated giant cells. Am J Dermatopathol 19:174-179.
17. Anand R Ma D, Alizadeh H, Comerford SA, Sambrook JF, Gething MJ, McLean IW, Niederkorn JY 1994 Characterization of intraocular tumors arising in transgenic mice. Invest Opthalmol Vis Sci 35:3533-3539.
18. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Martin TJ, Hirota H, Taga T, Kishimoto T, Suda TJ 1995 Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 182:1461-1468.
19. Horwood NJ, Udagawa N, Elliott J, Grail D, Okamura H, Kurimoto M, Dunn AR, Martin TJ, Gillespie MT 1998 Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest 101:595-603.
20. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FAO, Martin TJ 1986 Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest 78:355-365.
21. Akatsu T, Tamura T, Takahashi N, Udagawa N, Tanaka S, Sasaki T, Yamaguchi A, Nagata N, Suda TJ 1992 Preparation and characterization of a mouse osteoclast-like multinucleated cell population. J Bone Miner Res 7:1297-1306.
22. Chambers TJ, Revell PA, Fuller K, Athanasou NA 1984 Resorption of bone by isolated rabbit osteoclasts. J Cell Sci 66:383-399.
23. Horwood NJ, Kartsogiannis V, Quinn JMW, Romas E, Martin TJ, Gillespie MT 1999 Activated T-lymphocytes support osteoclast formation: A mechanism for rheumatoid arthritis. Biochem Biophys Res Commun 265:144-150.
24. 2 co-operates with TRANCE in osteoclast induction from hemopoietic precursors: Synergistic activationn of differentiation, cell spreading, and fusion. Endocrinology 140:1927-1935.
25. Vidal NO, Brandstrom H, Jonsson KB, Ohlsson C 1998 Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: Down-regulation by glucocorticoids. J Endocrinol 159:191-195.
26. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J 1999 RANK is essential for osteoclast and lymph node development. Genes Dev 13:2412-2424.
27. Quinn JMW, McGee JO'D, Athanasou NA 1994 Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cells. Endocrinology 134:2416-2423.
28. Owens JM, Gallagher AC, Chambers TJ 1996 Bone cells required for osteoclastic resorption but not for osteoclastic differentiation. Biochem Biophys Res Commun 222:225-229.
29. Jimi E, Akiyama S, Tsurakai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T 1999 Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 163: 434-442.
30. Chambers TJ, Fuller K 1985 Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci 76:155-165.
31. Hattersley G, Chambers TJ 1991 Effects of transforming growth factor beta 1 on the regulation of osteoclastic development and function. J Bone Miner Res 6:165-172.
32. Ikegame M, Rakopoulos M, Martin TJ, Moseley JM, Findlay DM 1996 Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures. J Bone Miner Res 11:456-465.